Photon counting computed tomography (PC-CT) for Coronary Artery Disease
Study Summary
This trial is testing whether PCD-CT provides more information about coronary artery disease than regular CT imaging.
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 0 Secondary · Reporting Duration: Through completion of CT exam, approximately 1 day
Trial Safety
Trial Design
2 Treatment Groups
Clinical Coronary CTA Cohort
1 of 2
Clinical Nuclear Medicine or MRI Cardiac Stress Test Cohort
1 of 2
Experimental Treatment
450 Total Participants · 2 Treatment Groups
Primary Treatment: Photon counting computed tomography (PC-CT) · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:About The Reviewer
Michael Gill - B. Sc.
First Published: October 19th, 2021
Last Reviewed: November 7th, 2022
Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.